Proteolytic inactivation of human leukocyte elastase

Area of Science:

• Biochemistry
• Enzymology
• Protease research

Background:

• Human leukocyte elastase (HLE) is a key protease involved in various physiological and pathological processes.
• Understanding HLE regulation and inactivation is crucial for therapeutic strategies.
• The susceptibility of HLE to other proteases has not been fully elucidated.

Purpose of the Study:

• To investigate the proteolytic inactivation of human leukocyte elastase (HLE) by different serine proteases.
• To identify factors influencing the rate of HLE inactivation.
• To explore potential inhibitory mechanisms against HLE proteolysis.

Main Methods:

• Incubation of purified human leukocyte elastase with various proteases including bovine pancreatic trypsin, porcine pancreatic elastase, and bovine pancreatic chymotrypsin.
• Assessing the enzymatic activity of HLE after incubation with different proteases.
• Evaluating the effect of specific inhibitors (benzamidine for trypsin, elastatinal for elastase) on HLE inactivation.

Main Results:

• Bovine pancreatic trypsin was found to proteolytically inactivate human leukocyte elastase.
• Porcine pancreatic elastase and bovine pancreatic chymotrypsin did not inactivate HLE.
• Neither trypsin, pancreatic elastase, nor chymotrypsin were susceptible to proteolysis by HLE or each other.
• Inhibition of trypsin with benzamidine or occupation of the elastase active site with elastatinal significantly slowed the trypsin-catalyzed inactivation of HLE.

Conclusions:

• Human leukocyte elastase is specifically inactivated by bovine pancreatic trypsin.
• The inactivation process is dependent on the active site of both trypsin and HLE.
• Pharmacological inhibition of trypsin or elastase active sites offers a potential strategy to modulate HLE activity in biological systems.